[ad_1]
Novel supplies developer and MIT spin-out OPT Industries has raised $15 million in Collection A funding to scale up the event of its novel 3D printing metamaterials and merchandise.
The capital injection may even be funneled into scaling up the manufacturing of the agency’s InstaSwab high-efficacy nasal swab developed throughout the pandemic.
“As a complicated manufacturing firm, we see the worth in constructing micro-scale applied sciences that resolve macro-scale challenges,” stated Jifei Ou, Founder and CEO of OPT. “OPT works with clients to design and manufacture a novel vary of metamaterials and merchandise for the healthcare, automotive, cosmetics and shopper items industries, and past.
“We are going to leverage the brand new financing to handle the demand for InstaSwab, gasoline product growth, scale operations, and develop the crew.”
OPT’s roll-to-roll 3D printing platform
OPT Industries emerged as a spin-off firm from MIT after seven years of R&D to develop its RAMP roll-to-roll 3D printing platform, which reportedly allows the printing of steady supplies at “limitless lengths” with micron-level precision.
The RAMP system delivers printing resolutions all the way down to 50µm, and claims to keep away from the upper prices and lead occasions related to typical tooling and world provide chains. Alongside its 3D printing platform, OPT additionally gives its personal line of proprietary polymers optimized for micron-scale photolithography 3D printing, and computational design capabilities.
After its institution as an impartial firm, OPT quickly scaled up its know-how throughout the pandemic to design and manufacture its 3D printed InstaSwab nasal swab for Covid-19 testing. The corporate claims the InstaSwab is as much as 20 occasions simpler in bacterial pattern elution than conventionally manufactured nasal swabs, and considerably simpler in viral pattern elution.
“Within the discipline of fabric science, metamaterials is a fast-developing space that holds monumental untapped potential,” stated Andrea Jackson, Director at Northpond Ventures, the lead investor in OPT’s Collection A funding spherical. “OPT’s platform is uniquely able to designing supplies with superior properties and superior efficiency throughout a spread of purposes together with absorption, cushion, insulation, and extra.
“The InstaSwab – made from exactly engineered fibrous constructions, every thinner than a human hair – exemplifies one of many standout improvements in novel metamaterials. OPT’s know-how enabled the design of a extra delicate medical diagnostic check, leading to real-world influence on affected person care.”
Funding the scale-up of RAMP
Shortly after opening its 14,000 sq. foot manufacturing facility final 12 months, OPT Industries has now closed a $15 million Collection A funding spherical to proceed scaling its operations.
The financing spherical was led by science-driven enterprise capital agency Northpond Ventures with participation from present traders Crosslink Capital and the MIT-affiliated E14 Fund.
OPT will use the funds to handle rising demand from its buyer base for novel metamaterials design and manufacturing, in addition to scaling up the manufacturing of its InstaSwab. The corporate may even use the capital injection to gasoline its product growth actions and to develop its crew.
Along with its financing information, OPT additionally introduced that UK-based care diagnostics firm LumiraDx had added the InstaSwab to its checklist of accepted nasal swabs for Covid-19 testing. InstaSwab is reportedly the primary 3D printed nasal swab to make the checklist.
“OPT is a primary instance of the following era of producing and the way it can have a fabric influence on constructing the availability chain of tomorrow,” stated Phil Boyer, Associate at Crosslink Capital. “With know-how that may allow speedy iterative design, end-to-end automated manufacturing, and steady regionally produced supplies for such a variety of purposes, OPT is quick turning into a crucial element for provide chain resilience.”
Going forwards, OPT reportedly plans to proceed turning its new 14,000 sq. foot facility right into a state-of-the-art additive manufacturing website able to producing industrial purposes past medical gadgets alone. In truth, the agency says its 3D printing platform and novel supplies will be leveraged for varied purposes throughout the automotive and shopper items industries, along with its healthcare potential.
“The speedy tempo at which OPT has moved its know-how from lab to market has been exceptional,” stated Habib Haddad, Managing Associate at E14 Fund. “Inside months of the corporate’s spin-out of MIT, OPT rapidly discovered its approach throughout healthcare and testing organizations nationwide.
“Amid rising demand by Fortune 500 international locations and market leaders for OPT’s merchandise, the 3D printing system that Jifei has pioneered has unlocked a wholly new paradigm for product creation from inception to manufacturing.”
Medical 3D printing investments
A number of companies have introduced medical-related funding updates and investments in current months.
As an example, 3D printer producer 3D Techniques set out its intentions to develop on its bioprinting program after buying Volumetric Biotechnologies for $400 million in October final 12 months. Shortly after, Lightforce Orthodontics raised $50 million in a Collection C funding spherical with the intention to scale up the manufacturing of its customized 3D printed braces and go-to-market efforts.
In December, 3D bioprinting specialist Inventia Life Science introduced the closure of a $25 million Collection B funding spherical to ramp up the roll-out of its RASTRUM 3D bioprinter, designed to handle the multibillion biomedical R&D and drug discovery market.
Most not too long ago, biotechnology agency Stämm Biotech raised $17 million in Collection A funding which it can plow into growing its next-generation 3D printed bioreactor. Cell-based cultures grown within the bioreactor may probably be leveraged for drug testing functions and growing medical therapies sooner or later.
Subscribe to the 3D Printing Business publication for the most recent information in additive manufacturing. You may also keep related by following us on Twitter and liking us on Fb.
Searching for a profession in additive manufacturing? Go to 3D Printing Jobs for a number of roles within the trade.
Subscribe to our YouTube channel for the most recent 3D printing video shorts, critiques and webinar replays.
Featured picture exhibits OPT Industries’ 3D printed InstaSwab nasal swab. Picture through OPT Industries.
[ad_2]
